Home ➤ Life Science ➤ Diagnostics ➤ Minimal Residual Disease Market
Minimal Residual Disease Market
Published date: March 2025 • Formats:
[email protected] +1 718 874 1545
Request Sample Schedule a Call

Table of Contents

Minimal Residual Disease MarketMinimal Residual Disease Market By Product Type (Flow Cytometry, Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), and Others), By Technology (Hematological Malignancy and Solid Tumors), By End-user (Hospitals & Specialty Clinics, Academic & Research Institutes, Diagnostic Laboratories, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

  • Published date: March 2025
  • Report ID: 142600
  • Number of Pages: 245
  • Format:
Fact Checked
Minimal Residual Disease Market https://market.us/report/minimal-residual-disease-market/
Cite this Research
  • keyboard_arrow_up
    • 1. Executive Summary
      • 1.1. Definition
      • 1.2. Market Snapshot
      • 1.3. Market Overview
      • 1.4. Segment Overview
      • 1.5. Regional Overview
      • 1.6. Competitive Landscape
      • 1.7. Taxonomy
    • 2. Global Market Overview
      • 2.1. Global Market Insights and Industry Overview
      • 2.2. Market Dynamics
        • 2.2.1. Drivers
        • 2.2.2. Restraints
        • 2.2.3. Opportunities
        • 2.2.4. Key Minimal Residual Disease Market Trends
      • 2.3. Regulatory Framework
      • 2.4. Opportunity Map Analysis
      • 2.5. Opportunity Orbits
      • 2.6. PESTLE Analysis
      • 2.7. PORTER’S Five Force Analysis
      • 2.8. Drivers & Restraints Impact Analysis
      • 2.9. Value Chain Analysis
        • 2.9.1. List of Raw Materials Suppliers
        • 2.9.2. List of Minimal Residual Disease Manufacturers
        • 2.9.3. List of Dealer/Distributors
      • 2.10. Regional Market Share and BPS Analysis
      • 2.11. Impact of Macro-economic Factors/Geopolitical Factors
    • 3. Global Minimal Residual Disease Market Analysis and Forecast, By Segment, 2020-2034
      • 3.1. Key Findings
      • 3.2. Global Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 3.3. Global Minimal Residual Disease Market Attractiveness Analysis, By Product Type
        • 3.3.1. Flow Cytometry
          • 3.3.1.1. Insights
          • 3.3.1.2. Key Takeaways
        • 3.3.2. Next Generation Sequencing (NGS)
          • 3.3.2.1. Insights
          • 3.3.2.2. Key Takeaways
        • 3.3.3. Polymerase Chain Reaction (PCR)
          • 3.3.3.1. Insights
          • 3.3.3.2. Key Takeaways
        • 3.3.4. Others
          • 3.3.4.1. Insights
          • 3.3.4.2. Key Takeaways
      • 3.4. Global Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 3.5. Global Minimal Residual Disease Market Attractiveness Analysis, By Technology
        • 3.5.1. Hematological Malignancy
          • 3.5.1.1. Insights
          • 3.5.1.2. Key Takeaways
            • 3.5.1.2.1. Lymphoma
            • 3.5.1.2.2. Leukemia
        • 3.5.2. Solid Tumors
          • 3.5.2.1. Insights
          • 3.5.2.2. Key Takeaways
      • 3.6. Global Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 3.7. Global Minimal Residual Disease Market Attractiveness Analysis, By End-user
        • 3.7.1. Hospitals & Specialty Clinics
          • 3.7.1.1. Insights
          • 3.7.1.2. Key Takeaways
        • 3.7.2. Academic & Research Institutes
          • 3.7.2.1. Insights
          • 3.7.2.2. Key Takeaways
        • 3.7.3. Diagnostic Laboratories
          • 3.7.3.1. Insights
          • 3.7.3.2. Key Takeaways
        • 3.7.4. Others
          • 3.7.4.1. Insights
          • 3.7.4.2. Key Takeaways
    • 4. Global Minimal Residual Disease Market Analysis and Forecast, By Region, 2020-2034
      • 4.1. Key Findings
      • 4.2. Global Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
        • 4.2.1. North America
          • 4.2.1.1. Regional Insights
        • 4.2.2. Europe
          • 4.2.2.1. Regional Insights
        • 4.2.3. Asia Pacific
          • 4.2.3.1. Regional Insights
        • 4.2.4. Latin America
          • 4.2.4.1. Regional Insights
        • 4.2.5. Middle East & Africa
          • 4.2.5.1. Regional Insights
      • 4.3. Global Minimal Residual Disease Market Attractiveness Analysis, By Region
    • 5. North America Minimal Residual Disease Market Analysis and Forecast, 2020-2034
      • 5.1. Key Findings
      • 5.2. North America Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 5.3. North America Minimal Residual Disease Market Attractiveness Analysis, By Product Type
      • 5.4. North America Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 5.5. North America Minimal Residual Disease Market Attractiveness Analysis, By Technology
      • 5.6. North America Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 5.7. North America Minimal Residual Disease Market Attractiveness Analysis, By End-user
      • 5.8. North America Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 5.9. North America Minimal Residual Disease Market Attractiveness Analysis, By Country
        • 5.9.1. The US
        • 5.9.2. Canada
    • 6. Europe Minimal Residual Disease Market Analysis and Forecast, 2020-2034
      • 6.1. Key Findings
      • 6.2. Europe Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 6.3. Europe Minimal Residual Disease Market Attractiveness Analysis, By Product Type
      • 6.4. Europe Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 6.5. Europe Minimal Residual Disease Market Attractiveness Analysis, By Technology
      • 6.6. Europe Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 6.7. Europe Minimal Residual Disease Market Attractiveness Analysis, By End-user
      • 6.8. Europe Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 6.9. Europe Minimal Residual Disease Market Attractiveness Analysis, By Country
        • 6.9.1. Germany
        • 6.9.2. The UK
        • 6.9.3. France
        • 6.9.4. Spain
        • 6.9.5. Italy
        • 6.9.6. Russia
        • 6.9.7. Netherland
        • 6.9.8. Rest of Europe
    • 7. Asia Pacific Minimal Residual Disease Market Analysis and Forecast, 2020-2034
      • 7.1. Key Findings
      • 7.2. Asia Pacific Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 7.3. Asia Pacific Minimal Residual Disease Market Attractiveness Analysis, By Product Type
      • 7.4. Asia Pacific Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 7.5. Asia Pacific Minimal Residual Disease Market Attractiveness Analysis, By Technology
      • 7.6. Asia Pacific Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 7.7. Asia Pacific Minimal Residual Disease Market Attractiveness Analysis, By End-user
      • 7.8. Asia Pacific Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 7.9. Asia Pacific Minimal Residual Disease Market Attractiveness Analysis, By Country
        • 7.9.1. China
        • 7.9.2. Japan
        • 7.9.3. South Korea
        • 7.9.4. India
        • 7.9.5. Australia
        • 7.9.6. New Zealand
        • 7.9.7. Singapore
        • 7.9.8. Thailand
        • 7.9.9. Vietnam
        • 7.9.10. Rest of Asia Pacific
    • 8. Latin America Minimal Residual Disease Market Analysis and Forecast, 2020-2034
      • 8.1. Key Findings
      • 8.2. Latin America Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 8.3. Latin America Minimal Residual Disease Market Attractiveness Analysis, By Product Type
      • 8.4. Latin America Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 8.5. Latin America Minimal Residual Disease Market Attractiveness Analysis, By Technology
      • 8.6. Latin America Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 8.7. Latin America Minimal Residual Disease Market Attractiveness Analysis, By End-user
      • 8.8. Latin America Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 8.9. Latin America Minimal Residual Disease Market Attractiveness Analysis, By Country
        • 8.9.1. Brazil
        • 8.9.2. Mexico
        • 8.9.3. Rest of Latin America
    • 9. Middle East & Africa Minimal Residual Disease Market Analysis and Forecast, 2020-2034
      • 9.1. Key Findings
      • 9.2. Middle East & Africa Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 9.3. Middle East & Africa Minimal Residual Disease Market Attractiveness Analysis, By Product Type
      • 9.4. Middle East & Africa Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 9.5. Middle East & Africa Minimal Residual Disease Market Attractiveness Analysis, By Technology
      • 9.6. Middle East & Africa Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 9.7. Middle East & Africa Minimal Residual Disease Market Attractiveness Analysis, By End-user
      • 9.8. Middle East & Africa Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 9.9. Middle East & Africa Minimal Residual Disease Market Attractiveness Analysis, By Country
        • 9.9.1. South Africa
        • 9.9.2. Saudi Arabia
        • 9.9.3. UAE
        • 9.9.4. Rest of Middle East & Africa
    • 10. Competitive Landscape & Company Profiles
      • 10.1. Market Competition Scenario Analysis, By Company
        • 10.1.1. Key Takeaways
      • 10.2. Overview of Major Market Players
      • 10.3. Competitor Landscape
      • 10.4. Strategic Mapping
      • 10.5. Company Life Cycle Analysis
      • 10.6. Company Market Share Analysis
      • 10.7. Company Profiles
        • 10.7.1. QIAGEN
          • 10.7.1.1. Company Details
          • 10.7.1.2. Business Overview
          • 10.7.1.3. Product Portfolio
          • 10.7.1.4. Financial Insights
          • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.1.6. SWOT Analysis
          • 10.7.1.7. Geographic Footprint
        • 10.7.2. Personalis
          • 10.7.2.1. Company Details
          • 10.7.2.2. Business Overview
          • 10.7.2.3. Product Portfolio
          • 10.7.2.4. Financial Insights
          • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.2.6. SWOT Analysis
          • 10.7.2.7. Geographic Footprint
        • 10.7.3. Invitae
          • 10.7.3.1. Company Details
          • 10.7.3.2. Business Overview
          • 10.7.3.3. Product Portfolio
          • 10.7.3.4. Financial Insights
          • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.3.6. SWOT Analysis
          • 10.7.3.7. Geographic Footprint
        • 10.7.4. Guardant Health
          • 10.7.4.1. Company Details
          • 10.7.4.2. Business Overview
          • 10.7.4.3. Product Portfolio
          • 10.7.4.4. Financial Insights
          • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.4.6. SWOT Analysis
          • 10.7.4.7. Geographic Footprint
        • 10.7.5. GRAIL, LLC
          • 10.7.5.1. Company Details
          • 10.7.5.2. Business Overview
          • 10.7.5.3. Product Portfolio
          • 10.7.5.4. Financial Insights
          • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.5.6. SWOT Analysis
          • 10.7.5.7. Geographic Footprint
        • 10.7.6. FOUNDATION MEDICINE, INC
          • 10.7.6.1. Company Details
          • 10.7.6.2. Business Overview
          • 10.7.6.3. Product Portfolio
          • 10.7.6.4. Financial Insights
          • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.6.6. SWOT Analysis
          • 10.7.6.7. Geographic Footprint
        • 10.7.7. F. Hoffmann-La Roche Ltd
          • 10.7.7.1. Company Details
          • 10.7.7.2. Business Overview
          • 10.7.7.3. Product Portfolio
          • 10.7.7.4. Financial Insights
          • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.7.6. SWOT Analysis
          • 10.7.7.7. Geographic Footprint
        • 10.7.8. Exact Sciences Corporation
          • 10.7.8.1. Company Details
          • 10.7.8.2. Business Overview
          • 10.7.8.3. Product Portfolio
          • 10.7.8.4. Financial Insights
          • 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.8.6. SWOT Analysis
          • 10.7.8.7. Geographic Footprint
    • 11. Methodology and Data Source
      • 11.1. Methodology/Research Approach
      • 11.2. Market Size Estimation
      • 11.3. Market Breakdown and Data Triangulation
      • 11.4. Data Source
      • 11.5. Secondary Sources
      • 11.6. Primary Sources
      • 11.7. Appendix
      • 11.8. Disclaimer
    • List of Tables
      • Table 1. Global Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 2. Global Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 3. Global Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 4. Global Minimal Residual Disease Market Value (US$ Mn), By Region, 2020-2034
      • Table 5. North America Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 6. North America Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 7. North America Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 8. North America Minimal Residual Disease Market Value (US$ Mn), By Country, 2020-2034
      • Table 9. The US Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 10. The US Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 11. The US Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 12. Canada Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 13. Canada Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 14. Canada Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 15. Europe Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 16. Europe Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 17. Europe Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 18. Europe Minimal Residual Disease Market Value (US$ Mn), By Country, 2020-2034
      • Table 19. Germany Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 20. Germany Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 21. Germany Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 22. The UK Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 23. The UK Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 24. The UK Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 25. France Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 26. France Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 27. France Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 28. Spain Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 29. Spain Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 30. Spain Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 31. Italy Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 32. Italy Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 33. Italy Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 34. Russia Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 35. Russia Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 36. Russia Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 37. Netherland Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 38. Netherland Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 39. Netherland Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 40. Rest of Europe Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 41. Rest of Europe Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 42. Rest of Europe Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 43. Asia Pacific Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 44. Asia Pacific Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 45. Asia Pacific Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 46. Asia Pacific Minimal Residual Disease Market Value (US$ Mn), By Country, 2020-2034
      • Table 47. China Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 48. China Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 49. China Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 50. India Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 51. India Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 52. India Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 53. Japan Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 54. Japan Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 55. Japan Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 56. South Korea Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 57. South Korea Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 58. South Korea Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 59. Australia Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 60. Australia Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 61. Australia Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 62. New Zealand Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 63. New Zealand Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 64. New Zealand Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 65. Singapore Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 66. Singapore Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 67. Singapore Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 68. Thailand Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 69. Thailand Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 70. Thailand Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 71. Vietnam Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 72. Vietnam Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 73. Vietnam Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 74. Rest of Asia Pacific Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 75. Rest of Asia Pacific Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 76. Rest of Asia Pacific Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 77. Latin America Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 78. Latin America Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 79. Latin America Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 80. Latin America Minimal Residual Disease Market Value (US$ Mn), By Country, 2020-2034
      • Table 81. Brazil Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 82. Brazil Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 83. Brazil Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 84. Mexico Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 85. Mexico Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 86. Mexico Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 87. Rest of Latin America Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 88. Rest of Latin America Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 89. Rest of Latin America Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 90. Middle East & Africa Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 91. Middle East & Africa Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 92. Middle East & Africa Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 93. Middle East & Africa Minimal Residual Disease Market Value (US$ Mn), By Country, 2020-2034
      • Table 94. South Africa Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 95. South Africa Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 96. South Africa Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 97. Saudi Arabia Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 98. Saudi Arabia Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 99. Saudi Arabia Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 100. UAE Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 101. UAE Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 102. UAE Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 103. Rest of Middle East & Africa Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 104. Rest of Middle East & Africa Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 105. Rest of Middle East & Africa Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
    • List of Figures
      • Figure 1. Global Minimal Residual Disease Market Snapshot: Market Value (US$ Mn), 2020-2034
      • Figure 2. Opportunity Map
      • Figure 3. Opportunity Orbit
      • Figure 4. Regional Market Share and BPS Analysis in Minimal Residual Disease Market
      • Figure 5. Global Minimal Residual Disease Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 6. Global Minimal Residual Disease Market Attractiveness Analysis, By Product Type
      • Figure 7. Global Minimal Residual Disease Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 8. Global Minimal Residual Disease Market Attractiveness Analysis, By Technology
      • Figure 9. Global Minimal Residual Disease Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 10. Global Minimal Residual Disease Market Attractiveness Analysis, By End-user
      • Figure 11. Global Minimal Residual Disease Market Analysis, By Region, 2020, 2024 and 2034
      • Figure 12. Global Minimal Residual Disease Market Attractiveness Analysis, By Region
      • Figure 13. North America Minimal Residual Disease Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 14. North America Minimal Residual Disease Market Attractiveness Analysis, By Product Type
      • Figure 15. North America Minimal Residual Disease Market (US$ Mn), by Flow Cytometry, 2020-2034
      • Figure 16. North America Minimal Residual Disease Market (US$ Mn), by Next Generation Sequencing (NGS), 2020-2034
      • Figure 17. North America Minimal Residual Disease Market (US$ Mn), by Polymerase Chain Reaction (PCR), 2020-2034
      • Figure 18. North America Minimal Residual Disease Market (US$ Mn), by Others, 2020-2034
      • Figure 19. North America Minimal Residual Disease Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 20. North America Minimal Residual Disease Market Attractiveness Analysis, By Technology
      • Figure 21. North America Minimal Residual Disease Market (US$ Mn), by Hematological Malignancy, 2020-2034
      • Figure 22. North America Minimal Residual Disease Market (US$ Mn), by Solid Tumors, 2020-2034
      • Figure 23. North America Minimal Residual Disease Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 24. North America Minimal Residual Disease Market Attractiveness Analysis, By End-user
      • Figure 25. North America Minimal Residual Disease Market (US$ Mn), by Hospitals & Specialty Clinics, 2020-2034
      • Figure 26. North America Minimal Residual Disease Market (US$ Mn), by Academic & Research Institutes, 2020-2034
      • Figure 27. North America Minimal Residual Disease Market (US$ Mn), by Diagnostic Laboratories, 2020-2034
      • Figure 28. North America Minimal Residual Disease Market (US$ Mn), by Others, 2020-2034
      • Figure 29. North America Minimal Residual Disease Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 30. North America Minimal Residual Disease Market Attractiveness Analysis, By Country
      • Figure 31. Europe Minimal Residual Disease Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 32. Europe Minimal Residual Disease Market Attractiveness Analysis, By Product Type
      • Figure 33. Europe Minimal Residual Disease Market (US$ Mn), by Flow Cytometry, 2020-2034
      • Figure 34. Europe Minimal Residual Disease Market (US$ Mn), by Next Generation Sequencing (NGS), 2020-2034
      • Figure 35. Europe Minimal Residual Disease Market (US$ Mn), by Polymerase Chain Reaction (PCR), 2020-2034
      • Figure 36. Europe Minimal Residual Disease Market (US$ Mn), by Others, 2020-2034
      • Figure 37. Europe Minimal Residual Disease Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 38. Europe Minimal Residual Disease Market Attractiveness Analysis, By Technology
      • Figure 39. Europe Minimal Residual Disease Market (US$ Mn), by Hematological Malignancy, 2020-2034
      • Figure 40. Europe Minimal Residual Disease Market (US$ Mn), by Solid Tumors, 2020-2034
      • Figure 41. Europe Minimal Residual Disease Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 42. Europe Minimal Residual Disease Market Attractiveness Analysis, By End-user
      • Figure 43. Europe Minimal Residual Disease Market (US$ Mn), by Hospitals & Specialty Clinics, 2020-2034
      • Figure 44. Europe Minimal Residual Disease Market (US$ Mn), by Academic & Research Institutes, 2020-2034
      • Figure 45. Europe Minimal Residual Disease Market (US$ Mn), by Diagnostic Laboratories, 2020-2034
      • Figure 46. Europe Minimal Residual Disease Market (US$ Mn), by Others, 2020-2034
      • Figure 47. Europe Minimal Residual Disease Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 48. Europe Minimal Residual Disease Market Attractiveness Analysis, By Country
      • Figure 49. Asia Pacific Minimal Residual Disease Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 50. Asia Pacific Minimal Residual Disease Market Attractiveness Analysis, By Product Type
      • Figure 51. Asia Pacific Minimal Residual Disease Market (US$ Mn), by Flow Cytometry, 2020-2034
      • Figure 52. Asia Pacific Minimal Residual Disease Market (US$ Mn), by Next Generation Sequencing (NGS), 2020-2034
      • Figure 53. Asia Pacific Minimal Residual Disease Market (US$ Mn), by Polymerase Chain Reaction (PCR), 2020-2034
      • Figure 54. Asia Pacific Minimal Residual Disease Market (US$ Mn), by Others, 2020-2034
      • Figure 55. Asia Pacific Minimal Residual Disease Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 56. Asia Pacific Minimal Residual Disease Market Attractiveness Analysis, By Technology
      • Figure 57. Asia Pacific Minimal Residual Disease Market (US$ Mn), by Hematological Malignancy, 2020-2034
      • Figure 58. Asia Pacific Minimal Residual Disease Market (US$ Mn), by Solid Tumors, 2020-2034
      • Figure 59. Asia Pacific Minimal Residual Disease Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 60. Asia Pacific Minimal Residual Disease Market Attractiveness Analysis, By End-user
      • Figure 61. Asia Pacific Minimal Residual Disease Market (US$ Mn), by Hospitals & Specialty Clinics, 2020-2034
      • Figure 62. Asia Pacific Minimal Residual Disease Market (US$ Mn), by Academic & Research Institutes, 2020-2034
      • Figure 63. Asia Pacific Minimal Residual Disease Market (US$ Mn), by Diagnostic Laboratories, 2020-2034
      • Figure 64. Asia Pacific Minimal Residual Disease Market (US$ Mn), by Others, 2020-2034
      • Figure 65. Asia Pacific Minimal Residual Disease Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 66. Asia Pacific Minimal Residual Disease Market Attractiveness Analysis, By Country
      • Figure 67. Latin America Minimal Residual Disease Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 68. Latin America Minimal Residual Disease Market Attractiveness Analysis, By Product Type
      • Figure 69. Latin America Minimal Residual Disease Market (US$ Mn), by Flow Cytometry, 2020-2034
      • Figure 70. Latin America Minimal Residual Disease Market (US$ Mn), by Next Generation Sequencing (NGS), 2020-2034
      • Figure 71. Latin America Minimal Residual Disease Market (US$ Mn), by Polymerase Chain Reaction (PCR), 2020-2034
      • Figure 72. Latin America Minimal Residual Disease Market (US$ Mn), by Others, 2020-2034
      • Figure 73. Latin America Minimal Residual Disease Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 74. Latin America Minimal Residual Disease Market Attractiveness Analysis, By Technology
      • Figure 75. Latin America Minimal Residual Disease Market (US$ Mn), by Hematological Malignancy, 2020-2034
      • Figure 76. Latin America Minimal Residual Disease Market (US$ Mn), by Solid Tumors, 2020-2034
      • Figure 77. Latin America Minimal Residual Disease Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 78. Latin America Minimal Residual Disease Market Attractiveness Analysis, By End-user
      • Figure 79. Latin America Minimal Residual Disease Market (US$ Mn), by Hospitals & Specialty Clinics, 2020-2034
      • Figure 80. Latin America Minimal Residual Disease Market (US$ Mn), by Academic & Research Institutes, 2020-2034
      • Figure 81. Latin America Minimal Residual Disease Market (US$ Mn), by Diagnostic Laboratories, 2020-2034
      • Figure 82. Latin America Minimal Residual Disease Market (US$ Mn), by Others, 2020-2034
      • Figure 83. Latin America Minimal Residual Disease Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 84. Latin America Minimal Residual Disease Market Attractiveness Analysis, By Country
      • Figure 85. Middle East & Africa Minimal Residual Disease Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 86. Middle East & Africa Minimal Residual Disease Market Attractiveness Analysis, By Product Type
      • Figure 87. Middle East & Africa Minimal Residual Disease Market (US$ Mn), by Flow Cytometry, 2020-2034
      • Figure 88. Middle East & Africa Minimal Residual Disease Market (US$ Mn), by Next Generation Sequencing (NGS), 2020-2034
      • Figure 89. Middle East & Africa Minimal Residual Disease Market (US$ Mn), by Polymerase Chain Reaction (PCR), 2020-2034
      • Figure 90. Middle East & Africa Minimal Residual Disease Market (US$ Mn), by Others, 2020-2034
      • Figure 91. Middle East & Africa Minimal Residual Disease Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 92. Middle East & Africa Minimal Residual Disease Market Attractiveness Analysis, By Technology
      • Figure 93. Middle East & Africa Minimal Residual Disease Market (US$ Mn), by Hematological Malignancy, 2020-2034
      • Figure 94. Middle East & Africa Minimal Residual Disease Market (US$ Mn), by Solid Tumors, 2020-2034
      • Figure 95. Middle East & Africa Minimal Residual Disease Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 96. Middle East & Africa Minimal Residual Disease Market Attractiveness Analysis, By End-user
      • Figure 97. Middle East & Africa Minimal Residual Disease Market (US$ Mn), by Hospitals & Specialty Clinics, 2020-2034
      • Figure 98. Middle East & Africa Minimal Residual Disease Market (US$ Mn), by Academic & Research Institutes, 2020-2034
      • Figure 99. Middle East & Africa Minimal Residual Disease Market (US$ Mn), by Diagnostic Laboratories, 2020-2034
      • Figure 100. Middle East & Africa Minimal Residual Disease Market (US$ Mn), by Others, 2020-2034
      • Figure 101. Middle East & Africa Minimal Residual Disease Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 102. Middle East & Africa Minimal Residual Disease Market Attractiveness Analysis, By Country
    • QIAGEN
    • Personalis
    • Invitae
    • Guardant Health
    • GRAIL, LLC
    • FOUNDATION MEDICINE, INC
    • Hoffmann-La Roche Ltd
    • Exact Sciences Corporation
Minimal Residual Disease Market
Minimal Residual Disease Market
Published date: March 2025
add_shopping_cartBuy Now get_appDownload Sample

Related Reports

Minimal Residual Disease Market
  • 142600
  • March 2025
    • ★★★★★
      ★★★★★
Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo

Our Clients

✖
Request a Sample Report
We'll get back to you as quickly as possible

✖
Request a Sample Report
We'll get back to you as quickly as possible

Find Help
Legal
Explore
Secured Payment Options
Secured Payment Options